1. China Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Shandong Xinhua Pharmaceutical Company Limited Class A

Shandong Xinhua Pharmaceutical Company Limited Class A

0.66
EUR
+0.02
(+2.33%)
0.02EPS
30.10P/E
1.27BMarket Cap
Oct 28Next Earn

Latest Stock Split

Jul 06, 2018

13:10

For every 10 shares held, investors received 13. The price per share adjusted from $0.72 to $0.56.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Jul 06, 2018
    Before$0.72
    Split ratio13:10
    After$0.56
    Forward

About Shandong Xinhua Pharmaceutical Company Limited Class A stock splits

Shandong Xinhua Pharmaceutical Company Limited Class A (FRA:XIN) operates in the Pharmaceuticals: other industry.

Shandong Xinhua Pharmaceutical Company Limited Class A company overview

When did Shandong Xinhua Pharmaceutical Company Limited Class A stock split?

Shandong Xinhua Pharmaceutical Company Limited Class A's most recent stock split was on July 6, 2018. It was a 13-for-10 forward split, so shareholders received 13 shares for every 10 they held.

How many times has Shandong Xinhua Pharmaceutical Company Limited Class A stock split?

Shandong Xinhua Pharmaceutical Company Limited Class A has split its stock once. This history records one forward split, on July 6, 2018.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Shandong Xinhua Pharmaceutical Company Limited Class A's 13-for-10 split on July 6, 2018, every 10 shares became 13 shares.

Will Shandong Xinhua Pharmaceutical Company Limited Class A split its stock again?

Shandong Xinhua Pharmaceutical Company Limited Class A has not announced a new split in our records. Its most recent split was on July 6, 2018, 8 years ago. Companies announce splits in advance, and any new FRA:XIN split will appear on this page.